Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease

被引:9
|
作者
Kourtidou, Christodoula [1 ]
Stangou, Maria [2 ]
Marinaki, Smaragdi [3 ]
Tziomalos, Konstantinos [1 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Hosp, Med Sch, Propedeut Dept Internal Med 1, Thessaloniki 54636, Greece
[2] Aristotle Univ Thessaloniki, Hippokration Hosp, Med Sch, Dept Nephrol, Thessaloniki 54642, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Hosp, Med Sch, Dept Nephrol & Renal Transplantat, Athens 11527, Greece
关键词
diabetes mellitus; diabetic kidney disease; cardiovascular risk; neutrophil gelatinase-associated lipocalin; kidney injury molecule-1; lipoxygenases; copeptin; matrix metalloproteinases; fibroblast growth factor-23; klotho; cubilin; GELATINASE-ASSOCIATED LIPOCALIN; DECLINING GLOMERULAR-FILTRATION; TO-CREATININE RATIO; ALL-CAUSE MORTALITY; ARGININE-VASOPRESSIN; PLASMA VASOPRESSIN; GENE POLYMORPHISM; SURROGATE MARKER; SOLUBLE KLOTHO; RENAL-DISEASE;
D O I
10.3390/ijms222011196
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Patients with diabetic kidney disease (DKD) are at very high risk for cardiovascular events. Only part of this increased risk can be attributed to the presence of diabetes mellitus (DM) and to other DM-related comorbidities, including hypertension and obesity. The identification of novel risk factors that underpin the association between DKD and cardiovascular disease (CVD) is essential for risk stratification, for individualization of treatment and for identification of novel treatment targets.In the present review, we summarize the current knowledge regarding the role of emerging cardiovascular risk markers in patients with DKD. Among these biomarkers, fibroblast growth factor-23 and copeptin were studied more extensively and consistently predicted cardiovascular events in this population. Therefore, it might be useful to incorporate them in risk stratification strategies in patients with DKD to identify those who would possibly benefit from more aggressive management of cardiovascular risk factors.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease
    Saritas, Turgay
    Reinartz, Sebastian Daniel
    Nadal, Jennifer
    Schmoee, Jonas
    Schmid, Matthias
    Marwan, Mohamed
    Achenbach, Stephan
    Stoerk, Stefan
    Wanner, Christoph
    Eckardt, Kai-Uwe
    Floege, Jurgen
    Schneider, Markus Peter
    Schlieper, Georg
    [J]. CLINICAL KIDNEY JOURNAL, 2020, 13 (04) : 571 - 579
  • [42] Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease
    Hung, Szu-Chun
    Kuo, Ko-Lin
    Peng, Ching-Hsiu
    Wu, Che-Hsiung
    Lien, Yu-Chung
    Wang, Yi-Chun
    Tarng, Der-Cherng
    [J]. KIDNEY INTERNATIONAL, 2014, 85 (03) : 703 - 709
  • [43] Frequency of Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Chronic Kidney Disease
    Sagun, Gul
    Kantarci, Gulcin
    Mesci, Banu
    Gungor, Sinem
    Turkoglu, Funda
    Yorulmaz, Elif
    Oguz, Aytekin
    [J]. CLINICAL MEDICINE & RESEARCH, 2010, 8 (3-4) : 135 - 141
  • [44] Novel Screening and Management of Fall Risk in Type 2 Diabetic Patients with Diabetic Kidney Disease
    Ikejima, Shin
    Kondo, Seiya
    Takahashi, Tomomi
    Uema, Mika
    Umezu, Junko
    Hirai, Aizan
    [J]. DIABETES, 2020, 69
  • [45] Cardiovascular Disease Risk Factors in Chronic Kidney Disease in Children
    Mitsnefes, Mark M.
    [J]. SEMINARS IN NEPHROLOGY, 2021, 41 (05) : 434 - 438
  • [46] Classic risk factors for cardiovascular disease in chronic kidney disease
    De Santo, NG
    Cirillo, M
    Iacono, G
    Capasso, G
    [J]. SEMINARS IN NEPHROLOGY, 2005, 25 (06) : 357 - 357
  • [47] Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
    Sarafidis, Pantelis A.
    Bakris, George L.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2366 - 2374
  • [48] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    [J]. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [49] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    [J]. High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [50] Cardiovascular Disease and Diabetic Kidney Disease
    Maqbool, Muhammad
    Cooper, Marke.
    Jandeleit-Dahm, Karin A. M.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 217 - 232